A national intervention to prevent the spread of Carbapenem-resistant enterobacteriaceae in Israeli post-acute care hospitals

Infection Control and Hospital Epidemiology

Volumn 35, Issue 7, 2014, Pages 802-809

  Ben David, Debby ^a   Masarwa, Samira ^a   Adler, Amos ^a   Mishali, Hagit ^a   Carmeli, Yehuda ^a   Schwaber, Mitchell J ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTERVENTION STUDY; ISRAEL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALIZATION; ISOLATION AND PURIFICATION; MIDDLE AGED; POLICY; PROCEDURES; VERY ELDERLY;

CARBAPENEM DERIVATIVE;

AGED; AGED, 80 AND OVER; CARBAPENEMS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFECTION CONTROL; ISRAEL; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; PROSPECTIVE STUDIES;

EID: 84902994471     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676876     Document Type: Article

References (39)

1. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006;27(9):920-925
2. Munoz-Price LS. Long-term acute care hospitals. Clin Infect Dis 2009;49(3):438-443
3. Furuno JP, Hebden JN, Standiford HC, et al. Prevalence of methicillin- resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 2008;36(7):468-471
4. Stephens C, Francis SJ, Abell V, DiPersio JR, Wells P. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control 2007;35(4):212-215
5. Barnes SL, Harris AD, Golden BL, Wasil EA, Furuno JP. Contribution of interfacility patient movement to overall methicillin- resistant Staphylococcus aureus prevalence levels. Infect Control Hosp Epidemiol 2011;32(11):1073-1078
6. Munoz-Price LS, Stemer A. Four years of surveillance cultures at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31(1):59-63
7. Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ. Long-term acute care hospital utilization after critical illness. JAMA 2010;303(22):2253-2259
8. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000;31(3):752-756
9. Roup BJ, Roche JC, Pass M. Infection control program disparities between acute and long-term care facilities in Maryland. Am J Infect Control 2006;34(3):122-127
10. Jones M, Samore MH, Carter M, Rubin MA. Long-term care facilities in Utah: a description of human and information technology resources applied to infection control practice. Am J Infect Control 2012;40(5):446-450
11. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 2008;300(24):2911-2913
12. Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011;17(10): 1791-1798
13. Cuzon G, Naas T, Truong H, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 2010;16(9):1349-1356
14. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9(4):228-236
15. Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother 2009;53(2): 818-820
16. Sisto A, D'Ancona F, Meledandri M, et al. Carbapenem nonsusceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012. Euro Surveill 2012;17(33). pii: 20247
17. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007;30(6):525-529
18. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe. Euro Surveill 2008;13(47). pii: 19045
19. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52(7):848-855
20. Ben-David D, Masarwa S, Navon-Venezia S, et al. Carbapenemresistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 2011;32(9):845-853.
21. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. Approved standard MS100-S20. Wayne, PA: Clinical and Laboratory Standards Institute, 2010
22. Pittet D, Allegranzi B, Boyce J; World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts. The World Health Organization guidelines on hand hygiene in health care and their consensus recommendations. Infect Control Hosp Epidemiol 2009; 30(7):611-622
23. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35(10 suppl 2):S65-S164
24. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin- resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344(19):1427-1433
25. Chitnis AS, Caruthers PS, Rao AK, et al. Outbreak of carbapenem- resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 2012;33(10):984-992
26. Oteo J, Navarro C, Cercenado E, et al. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 2006;44(7):2359-2366
27. Viau RA, Hujer AM, Marshall SH, et al. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in northeast Ohio. Clin Infect Dis 2012;54(9):1314-1321
28. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemasea producing Enterobacteriaceae. Clin Infect Dis 2011;53(6):532-540
29. Carbapenem-resistant Klebsiella pneumoniae associated with a long-term care facility, West Virginia, 2009-2011. MMWR Morb Mortal Wkly Rep 2011;60(41):1418-1420
30. Marchaim D, Chopra T, Bogan C, et al. The burden of multidrug- resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control 2012;40(8):760-765
31. Prabaker K, Lin MY, McNally M, et al. Transfer from highacuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriacea: a multihospital study. Infect Control Hosp Epidemiol 2012; 33(12):1193-1199
32. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014;58(5):697-703
33. Jarlier V, Trystram D, Brun-Buisson C, et al. Curbing methicillin- resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010;170(6):552-559
34. Nicolle LE. Antimicrobial resistance in long-term care facilities. Future Microbiol 2012;7(2):171-174
35. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29(10):966-968
36. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem- resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31(6):620-626
37. Ciobotaro P, Oved M, Nadir E, Bardenstein R, Zimhony O. An effective intervention to limit the spread of an epidemic carbapenem- resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011;39(8): 671-677
38. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30(5): 447-452
39. Thurlow CJ, Prabaker K, Lin MY, Lolans K, Weinstein RA, Hayden MK. Anatomic sites of patient colonization and environmental contamination with Klebsiella pneumoniae carbapenemase- producing Enterobacteriaceae at long-term acute care hospitals. Infect Control Hosp Epidemiol 2013;34(1):56-61.